BioNTech SE ( BNTX) - Key Metrics
BNTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.67 | -$1.23 | $1.22 | $0.97 |
| 2025Q3 | $6.35 | -$0.12 | $3.57 | $3.39 |
| 2025Q2 | $1.08 | -$1.60 | $0.61 | $0.48 |
| 2025Q1 | $0.76 | -$1.73 | -$3.25 | -$5.82 |
BNTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -16.50 |
| 2025Q3 | ? | -173.12 |
| 2025Q2 | ? | -14.27 |
| 2025Q1 | ? | -11.91 |
BNTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.50% | ? |
| 2025Q4 | 1.20% | ? |
| 2025Q3 | 4.04% | ? |
| 2025Q2 | 3.21% | ? |
| 2025Q1 | -7.28% | ? |
BNTX
Price: $88.52
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.97 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 379200
Market Capitalization: 23.6 billion